Stay updated on APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial

Sign up to get notified when there's something new on the APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page now shows Revision: v3.5.4, replacing the previous v3.5.3, indicating a new page version. This change is a metadata update and does not alter visible content or functionality.
    Difference
    0.0%
    Check dated 2026-05-15T23:53:32.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page’s UI/version label was updated from Revision v3.5.2 to v3.5.3 on the bottom of the ClinicalTrials.gov record, without any changes to the underlying study details.
    Difference
    0.0%
    Check dated 2026-04-24T17:10:20.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2. Deleted Revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-17T14:09:42.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Two additional MeSH terms related to glomerulonephritis were added to the Additional Relevant MeSH Terms section, potentially improving searchability.
    Difference
    0.1%
    Check dated 2026-04-03T05:53:03.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added, replacing the previous Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-19T23:42:50.000Z thumbnail image
  8. Check
    94 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added, and notices about government funding lapse and operating status were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-12T02:09:56.000Z thumbnail image

Stay in the know with updates to APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial page.